01 3AVELUMAB
02 1CETRORELIX (CETRORELIX ACETATE)
03 2CETRORELIX ACETATE
04 4CHORIOGONADOTROPIN ALFA
05 2CLADRIBINE
06 1CLOMIPHENE CITRATE
07 6FOLLITROPIN ALFA
08 12FOLLITROPIN ALFA/BETA
09 4INTERFERON BETA-1A
10 23LEVOTHYROXINE SODIUM
11 4LUTROPIN ALFA
12 7METFORMIN HYDROCHLORIDE
13 3MITOXANTRONE HYDROCHLORIDE
14 1PROGESTERONE
15 3SERMORELIN ACETATE
16 14SOMATROPIN
17 4SOMATROPIN RECOMBINANT
18 1TEPOTINIB (TEPOTINIB HYDROCHLORIDE)
19 1TEPOTINIB HYDROCHLORIDE
20 1WATER
01 32EMD SERONO
02 27EMD SERONO INC
03 27EMD SERONO, A DIVISION OF EMD INC., CANADA
04 11MERCK KGAA
01 1GEL
02 20INJECTABLE;INJECTION
03 1INJECTABLE;INTRAVENOUS
04 14INJECTABLE;SUBCUTANEOUS
05 5POWDER FOR SOLUTION
06 2POWDER;SUBCUTANEOUS
07 19SOLUTION
08 2TABLET
09 2TABLET, EXTENDED RELEASE;ORAL
10 31TABLET;ORAL
01 20.025MG
02 20.05MG
03 20.075MG
04 20.088MG
05 20.112MG
06 20.125MG
07 10.137MG
08 20.15MG
09 20.175MG
10 20.1MG
11 20.25MG/VIAL
12 20.2MG
13 20.3MG
14 11,050 IU/VIAL
15 210MG
16 1132MCG/1.5ML
17 1150 IU/0.25ML
18 2150 IU/VIAL
19 1150UNIT/0.48ML
20 11GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
21 11ML/KIT
22 320MG/ML
23 1225MG
24 1225UNIT/0.72ML
25 122MCG/0.5ML
26 2250MCG/0.5ML
27 1300 IU/0.5ML
28 2300UNIT/0.48ML
29 237.5 IU/VIAL
30 144MCG/0.5ML
31 1450 IU/0.75ML
32 1450 IU/VIAL
33 2450UNIT/0.72ML
34 1450UNIT/1.44ML
35 34MG/VIAL
36 15.83MG/ML
37 2500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
38 150MG
39 15MG/KIT
40 45MG/VIAL
41 1625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
42 166MCG/1.5ML
43 16MG/0.5ML (6MG/0.5ML)
44 36MG/VIAL
45 275 IU/VIAL
46 2750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
47 175UNIT/VIAL
48 18%
49 38.8MG/VIAL
50 1850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 28MG/ML
52 1900 IU/1.5ML
53 2900UNIT/1.44ML
54 1EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
55 1EQ 0.25MG /0.5ML
56 1EQ 0.25MG BASE/VIAL
57 1EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
58 1EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
59 1EQ 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
60 1EQ 225MG BASE
61 1EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
62 1EQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
63 1EQ 3MG BASE/VIAL
01 27Canada
02 70USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 761049
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INTRAVENOUS
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 761078
Regulatory Info :
Registration Country : USA
Regulatory Info : SCHEDULE D
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging : 10ML VIAL
Approval Date :
Application Number : 2469723
Regulatory Info : SCHEDULE D
Registration Country : Canada
Regulatory Info : PRESCRIPTION
Registration Country : Canada
CETRORELIX (CETRORELIX ACETATE)
Dosage Form : POWDER FOR SOLUTION
Brand Name : CETROTIDE
Dosage Strength : 0.25MG/VIAL
Packaging : 1ML
Approval Date :
Application Number : 2247766
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;SUBCUTANEOUS
Brand Name : CETROTIDE
Dosage Strength : EQ 0.25MG BASE/VIAL
Packaging :
Approval Date : 2000-08-11
Application Number : 21197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : POWDER;SUBCUTANEOUS
Brand Name : CETROTIDE
Dosage Strength : EQ 3MG BASE/VIAL
Packaging :
Approval Date : 2000-08-11
Application Number : 21197
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : OVIDREL
Dosage Strength : 0.25MG/VIAL
Packaging :
Approval Date :
Application Number : 21149
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Brand Name : OVIDREL
Dosage Strength : EQ 0.25MG /0.5ML
Packaging :
Approval Date :
Application Number : 21149
Regulatory Info :
Registration Country : USA
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : OVIDREL
Dosage Strength : 250MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2262088
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : OVIDREL
Dosage Strength : 250MCG/0.5ML
Packaging : 0.5ML/3ML
Approval Date :
Application Number : 2371588
Regulatory Info : PRESCRIPTION
Registration Country : Canada
